Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Gray hair can potentially be reversed, leading to new treatments.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New hair products are being developed to keep hair and scalp healthy for everyone.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

New technologies in acupuncture and biosensors show promise for better medical treatments and healing.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

The new system can grow hair in the lab and test hair growth treatments.

The new method for isolating stem cells from fat is simple and effective, producing cells that grow faster and are better for hair regeneration.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

A new mouse model for vitiligo helps study immune responses and potential treatments.

The new facial treatment improved wrinkles and skin thickness, with most patients seeing results within a month, despite some temporary swelling and bruising.

Stem cells could potentially rebuild missing structures in wounds, improving facial skin replacement techniques.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.